P 293 LYS 12 -9.493 -9.781
P 294 VAL 11 -14.938 -14.485
P 295 ILE 30 -17.337 -18.793
P 296 HIS 21 -18.805 -19.058
P 297 GLY 35 -20.434 -22.109
P 298 CYS 31 -22.048 -23.077
P 299 ASN 18 -18.786 -18.695
P 300 PHE 37 -18.593 -20.709
P 301 SER 25 -14.392 -15.612
P 302 SER 5 -11.503 -10.755
P 303 ASN 18 -10.032 -10.948
P 304 VAL 4 -10.744 -9.968
P 305 SER 21 -9.624 -10.933
P 306 SER 0 -6.449 -5.707
P 307 LYS 16 -8.026 -8.943
P 308 HIS 31 -13.645 -15.641
P 309 THR 3 -15.020 -13.638
P 310 PHE 31 -18.046 -19.536
P 311 THR 18 -17.853 -17.870
P 312 ASP 20 -18.291 -18.488
P 313 SER 18 -17.764 -17.791
P 314 LEU 25 -17.398 -18.273
P 315 ASP 6 -15.526 -14.430
P 316 ILE 29 -14.779 -16.415
P 317 SER 8 -10.343 -10.074
P 318 LEU 10 -10.273 -10.242
P 319 VAL 28 -11.265 -13.189
P 320 ASP 4 -7.671 -7.249
P 321 ASP 2 -6.418 -5.910
P 322 SER 0 -6.392 -5.657
P 323 ALA 17 -10.031 -10.832
P 324 HIS 7 -11.476 -10.961
P 325 ILE 22 -15.130 -15.920
P 326 SER 18 -19.260 -19.115
P 327 CYS 29 -20.559 -21.529
P 328 ASN 9 -19.158 -17.990
P 329 VAL 36 -19.375 -21.287
P 330 HIS 4 -16.052 -14.666
P 331 LEU 36 -15.445 -17.809
P 332 SER 4 -9.116 -8.527
P 333 GLU 14 -6.985 -7.792
P 334 PRO 0 -2.303 -2.038 <=B
P 335 LYS 3 -4.715 -4.518
P 336 TYR 33 -8.592 -11.399
P 337 ASN 2 -8.333 -7.605
P 338 HIS 26 -14.078 -15.449
P 339 LEU 20 -16.762 -17.135
P 340 VAL 35 -19.019 -20.857
P 341 GLY 30 -20.270 -21.389
P 342 LEU 38 -21.355 -23.270
P 343 ASN 29 -19.327 -20.439
P 344 CYS 29 -18.505 -19.712
P 345 PRO 20 -14.175 -14.845
P 346 GLY 25 -12.915 -14.305
P 347 ASP 9 -13.801 -13.249
P 348 ILE 29 -17.701 -19.000
P 349 ILE 20 -16.389 -16.804
P 350 PRO 17 -15.528 -15.697
P 351 ASP 4 -15.073 -13.799
P 352 CYS 35 -18.842 -20.700
P 353 PHE 36 -18.345 -20.375
P 354 PHE 4 -15.432 -14.117
P 355 GLN 14 -15.217 -15.077
P 356 VAL 29 -17.536 -18.855
P 357 TYR 24 -15.997 -16.917
P 358 GLN 14 -14.287 -14.254
P 359 PRO 19 -11.344 -12.224
P 360 GLU 4 -6.269 -6.008
P 361 SER 7 -5.556 -5.722
P 362 GLU 5 -8.416 -8.023
P 363 GLU 14 -7.054 -7.853
P 364 LEU 4 -8.675 -8.137
P 365 GLU 1 -7.778 -6.998
P 366 PRO 25 -10.573 -12.232
P 367 SER 5 -7.091 -6.850
P 368 ASN 10 -8.668 -8.821
P 369 ILE 15 -11.499 -11.901
P 370 VAL 14 -12.845 -12.978
P 371 TYR 10 -13.309 -12.928
P 372 LEU 27 -15.508 -16.829
P 373 ASP 7 -9.959 -9.619
P 374 SER 8 -7.094 -7.199
P 375 GLN 25 -11.086 -12.686
P 376 ILE 35 -11.790 -14.459
P 377 ASN 9 -6.442 -6.736
P 378 ILE 26 -6.813 -9.019
P 379 GLY 6 -6.450 -6.398
P 380 ASP 1 -7.413 -6.676
P 381 ILE 28 -11.646 -13.527
P 382 GLU 11 -11.612 -11.542
P 383 TYR 15 -14.157 -14.254
P 384 TYR 21 -15.249 -15.911
P 385 GLU 11 -14.508 -14.105
P 386 ASP 21 -11.758 -12.821
P 387 ALA 4 -10.212 -9.498
P 388 GLU 22 -7.989 -9.600
P 389 GLY 13 -6.153 -6.940
P 390 ASP 14 -8.655 -9.270
P 391 ASP 25 -11.965 -13.464
P 392 LYS 18 -14.300 -14.725
P 393 ILE 26 -17.414 -18.401
P 394 LYS 24 -18.507 -19.139
P 395 LEU 25 -17.960 -18.770
P 396 PHE 26 -17.272 -18.276
P 397 GLY 11 -15.087 -14.617
P 398 ILE 37 -13.787 -16.457
P 399 VAL 6 -8.056 -7.820
P 400 GLY 11 -5.676 -6.288
P 401 SER 8 -5.542 -5.825
P 402 ILE 29 -7.414 -9.896
P 403 PRO 9 -4.388 -4.918
P 404 LYS 8 -4.458 -4.865
P 405 THR 14 -8.368 -9.015
P 406 THR 23 -11.560 -12.875
P 407 SER 13 -16.500 -16.098
P 408 PHE 29 -17.957 -19.227
P 409 THR 23 -19.953 -20.304
P 410 CYS 36 -20.972 -22.701
P 411 ILE 24 -19.971 -20.434
P 412 CYS 36 -19.531 -21.425
P 413 LYS 13 -14.641 -14.453
P 414 LYS 28 -10.889 -12.857
P 415 ASP 11 -6.350 -6.884
P 416 LYS 4 -5.970 -5.743
P 417 LYS 19 -10.504 -11.481
P 418 SER 15 -14.381 -14.453
P 419 ALA 28 -18.976 -20.014
P 420 TYR 24 -20.736 -21.112
P 421 MET 42 -22.034 -24.330
P 422 THR 13 -20.240 -19.408
P 423 VAL 36 -20.302 -22.107
P 424 THR 8 -16.491 -15.515
P 425 ILE 30 -15.021 -16.743
P 426 ASP 10 -9.830 -9.849
P 427 SER 6 -6.696 -6.616
P 428 ALA 1 -2.011 -1.895 <=B
P 429 GLY 18 -2.666 -4.429

Identified 2 B-Cell epitope residues out of 137 total residues